Compare Enveric Biosciences Inc (ENVB) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Star Bulk Carriers Corp — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Star Bulk Carriers Corp trades at $26.33 (market cap $2.94B). The key difference: Star Bulk Carriers Corp is far larger — about 552.6× Enveric Biosciences Inc's market cap, and Star Bulk Carriers Corp pays a 3.91% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SBLK | |
|---|---|---|
Market Cap | $5.32M | $2.94B |
Sector | Health | Industrials |
52-Week High | $17.40 | $28.21 |
52-Week Low | $1.28 | $16.79 |
Enterprise Value | $408.82K | $3.64B |
Dividend Yield | — | 3.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
Star Bulk Carriers (SBLK) trades at $26.33, down 0.88% on the day, with a bullish technical signal driven by moving averages. The company reported strong earnings beats in Q4 2025 and Q1 2026, with Q2 2026 EPS expected at $0.96. Fundamentals show solid profitability with a net income margin of 13.01% and a healthy EV/EBITDA of 9.83. Recent news highlights robust dry bulk rates supporting high dividend yields and fleet modernization efforts.
The outlook for SBLK is positive, supported by strong spot rates and a disciplined capital allocation policy returning cash to shareholders. Investment opportunities include potential dividend yields above 10% and earnings growth from fleet efficiency. Key risks involve volatility in dry bulk shipping rates and broader economic pressures impacting global trade demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
